Tandem Diabetes Care, Inc. (TNDM)

NASDAQ: TNDM · Real-Time Price · USD
32.28
-1.09 (-3.27%)
Dec 4, 2024, 4:00 PM EST - Market closed
-3.27%
Market Cap 2.12B
Revenue (ttm) 854.35M
Net Income (ttm) -126.78M
Shares Out 65.68M
EPS (ttm) -1.94
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,265,399
Open 33.20
Previous Close 33.37
Day's Range 31.64 - 33.47
52-Week Range 21.07 - 53.69
Beta 1.35
Analysts Buy
Price Target 52.50 (+62.64%)
Earnings Date Nov 6, 2024

About TNDM

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company’s flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and deliverin... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Nov 14, 2013
Employees 2,400
Stock Exchange NASDAQ
Ticker Symbol TNDM
Full Company Profile

Financial Performance

In 2023, Tandem Diabetes Care's revenue was $747.72 million, a decrease of -6.68% compared to the previous year's $801.22 million. Losses were -$222.61 million, 135.3% more than in 2022.

Financial Statements

Analyst Forecast

According to 16 analysts, the average rating for TNDM stock is "Buy." The 12-month stock price forecast is $52.5, which is an increase of 62.64% from the latest price.

Price Target
$52.5
(62.64% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Tandem Diabetes Care Announces Upcoming Conference Presentations

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the ...

13 days ago - Business Wire

Tandem Diabetes Care, Inc. (TNDM) Q3 2024 Earnings Conference Call Transcript

Tandem Diabetes Care, Inc. (TNDM) Q3 2024 Earnings Conference Call Transcript

27 days ago - Seeking Alpha

Tandem Diabetes Care Announces Third Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 3...

4 weeks ago - Business Wire

Tandem Diabetes Care Announces Upcoming Conference Participation

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will host meetings and present a comp...

5 weeks ago - Business Wire

Tandem Diabetes Care to Announce Third Quarter 2024 Financial Results on November 6, 2024

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2024 results after the financial m...

2 months ago - Business Wire

Tandem Diabetes Insulin Pump Demand to Surge Despite Popular Demand Of Weight Loss Drugs, Bullish Analyst Says

RBC Capital Markets initiated coverage on Tandem Diabetes Care, Inc. TNDM, a global insulin delivery and diabetes technology company that manufactures and sells advanced automated insulin delivery sys...

2 months ago - Benzinga

Tandem t:slim X2 Insulin Pump Now Compatible with Lyumjev Ultra-rapid Acting Insulin in European Union

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #diabetes--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2 insulin pump w...

2 months ago - Business Wire

Tandem Diabetes Care to Release Updated iOS t:connect Mobile App for t:slim X2 Insulin Pump Users Impacted by March 2024 Nationwide Recall

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) today announced the planned release of version 2.8.2 of its Apple iOS t:connect mobile app in the United States on August 20, 2024...

3 months ago - Business Wire

Tandem Diabetes Care Provides Update on March 2024 Nationwide Recall of t:connect Mobile App for iOS Devices

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) today provided an update on the March 2024 recall of its Apple iOS t:connect mobile app in the United States relating to an issue ...

4 months ago - Business Wire

Tandem Diabetes Care, Inc. (TNDM) Q2 2024 Earnings Call Transcript

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q2 2024 Earnings Conference Call August 1, 2024 4:30 PM ET Company Participants Susan Morrison - Executive Vice President and Chief Administrative Officer. Jo...

4 months ago - Seeking Alpha

Tandem Diabetes Care Announces Second Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 20...

4 months ago - Business Wire

Tandem Diabetes Care Announces Upcoming Conference Presentation

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the ...

4 months ago - Business Wire

Tandem Diabetes Care and Dexcom Announce the t:slim X2 Insulin Pump with Dexcom G7 CGM Compatibility is Authorized for Sale by Health Canada

MARKHAM, Ontario--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. (Nasdaq: DXCM) today announced the updated t:slim X2™ insulin pump software is compatibl...

Other symbols: DXCM
4 months ago - Business Wire

Tandem Diabetes Care to Announce Second Quarter 2024 Financial Results on August 1, 2024

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2024 results after the financial ...

5 months ago - Business Wire

Tandem Mobi Improves Quality of Life for People Living With Type 1 Diabetes in New Data Shared at American Diabetes Association Scientific Sessions

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #TandemMobi--Tandem Diabetes Care today presented positive real-world data from a Tandem Mobi user satisfaction survey at the 2024 ADA Scientific Sessions.

5 months ago - Business Wire

Tandem Diabetes Care Appoints Jean-Claude Kyrillos as Chief Operating Officer

SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Jean-Claude “JC”...

5 months ago - Business Wire

Tandem Diabetes Care to Present New Early User Insights on the Tandem Mobi System at the American Diabetes Association's 84th Scientific Sessions

SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced its schedule of presentations for t...

6 months ago - Business Wire

Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM

SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. (Nasdaq: DXCM), today announced that the Tandem Mobi insulin pump with Control-IQ technology is...

Other symbols: DXCM
6 months ago - Business Wire

Tandem Diabetes Care: Recent Rally Fully Deserved, Likely More Upside Here

Tandem Diabetes Care is a company that specializes in diabetes management products, most notably insulin pumps for T1D patients. TNDM stock has been performing well, with a 100% increase in value over...

6 months ago - Seeking Alpha

Tandem Diabetes Care, Inc. (TNDM) Q1 2024 Earnings Call Transcript

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2024 Earnings Conference Call May 2, 2024 4:30 PM ET Company Participants Susan Morrison - Executive Vice President and Chief Administrative Officer. John ...

7 months ago - Seeking Alpha

Tandem Diabetes Care Announces First Quarter 2024 Financial Results and Updates Full Year 2024 Financial Guidance

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2...

7 months ago - Business Wire

Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2024 results after the financial m...

8 months ago - Business Wire

Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today the pricing of $275.0 million aggregate principal amou...

9 months ago - Business Wire

Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today that it intends to offer, subject to market conditions...

9 months ago - Business Wire

Tandem Diabetes Care, Inc. (TNDM) Q4 2023 Earnings Call Transcript

Tandem Diabetes Care, Inc. (TNDM) Q4 2023 Earnings Call Transcript

10 months ago - Seeking Alpha